Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04310787

Long-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver Failure

The Investigation on Long-term Outcomes and Prognostic Factors of Patients With Hepatitis B Related Acute-on-chronic Liver Failure

Status
Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Third Affiliated Hospital, Sun Yat-Sen University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study is to investigate the long-term outcomes and prognostic risk factors in patients recovered from hepatitis B virus related acute on-chronic liver failure.

Detailed description

Chronic acute liver failure (ACLF) is a systemic multi-organ failure driven by acute liver injury in the basis of chronic liver disease. The main cause of chronic acute liver failure in China is hepatitis b virus infection.Previous studies on the prognosis of acute on-chronic liver failure mainly focused on the short-term survival rate and the follow-up time was relatively short, while the study on the long-term prognosis of patients with spontaneous recovery of chronic acute liver failure was still lack-ing. Thus,this study mainly retrospectively analyzed the clinical data of patients with chronic hepatitis b related acute liver failure admitted to the department of infectious diseases, the third affiliated hospital of sun yat-sen university, and con-ducted telephone follow-up survey to analyze the long-term prognosis of patients with chronic hepatitis b related acute on-chronic liver failure.

Conditions

Timeline

Start date
2020-05-15
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2020-03-17
Last updated
2024-11-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04310787. Inclusion in this directory is not an endorsement.